Clinical Trial Update: Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the additive effect of Mutaflor probiotic in patients with Ulcerative Colitis on 5-ASA therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mutaflor (Escherichia coli Nissle 1917)

Snippet

Sponsor: Kangbuk Samsung Hospital | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED